Loading…
Veteran Prescription Continuity Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
57pct
18d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Veteran Prescription Continuity Act This bill amends the National Defense Authorization Act for Fiscal Year 2016 to direct the Department of Veterans Affairs (VA) to furnish an individual who is transitioning from Department of Defense (DOD)- to VA-furnished medical treatment any pharmaceutical agent not included in the joint uniform formulary if a DOD health care provider determines that the pharmaceutical agent is critical for the transition. The VA shall furnish an individual with such pharmaceutical agent: (1) beginning when the individual enrolls in the VA health care system, and (2) ending when a DOD health care provider determines that the individual does not require the pharmaceutical agent.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2016 · third_quarter · Veterans
SUPPORT FOR S.1641 "THE JASON SIMCAKOSKI MEMORIAL OPIOID SAFETY ACT;" SUPPORT FOR S.3032 "THE VETERANS' COMPENSATION COST-OF-LIVING ADJUSTMENT ACT OF 2016;" SUPPORT FOR HR 4946,"EARN IT ACT;" URGE CONGRESS TO UTILIZE THE NDAA TO EXTEND "THE SPECIAL SURVIVOR INDEMNITY ALLOWANCE (SSIA);" SUPPORT FOR CERTAIN SECTIONS OF H.R. 5620 "VA ACCOUNTABILITY FIRST AND APPEALS MODERNIZATION ACT OF 2016;" OPPOSE SECTION 563, "ACCESS TO DOD INSTALLATIONS BY INSTITUTIONS OF HIGHER EDUCATION" AS PART OF THE FY 2017 NATIONAL DEFENSE AUTHORIZATION BILL; SUPPORT FOR H.R. 3963 "PURPLE HEART HEROES ACT OF 2015;" SUPPORT FOR SECTIONS 536 & 536A OF SENATE BILL S.2943 AND SUPPORTIVE LANGUAGE FROM PAGE 148 OF HOUSE REPORT 114-537 OF THE NDAA AND HR 4683 & S.1567 "FAIRNESS FOR VETERANS ACT;" SUPPORT FOR H.R.6124 THE "HOUSING OUR MILITARY SERVICEMEMBERS ACT;" SUPPORT FOR HR 5932 THE "VETERANS PREVENTATIVE HEALTH COVERAGE FAIRNESS ACT;" SUPPORT FOR THE IVF (REPRODUCTION) PROVISION IN HR 4974 "MILCON/VA APPROPRIATIONS ACT OF 2017;" SUPPORT FOR HR 5932 THE "VETERANS PREVENTIVE HEALTH COVERAGE FAIRNESS ACT;" SUPPORT FOR HR 3471 "VETERANS MOBILITY SAFETY ACT OF 2016;" SUPPORT FOR HR 5620 "VA ACCOUNTABILITY FIRST AND APPEALS MODERNIZATION ACT OF 2016;" SUPPORT FOR HR 6234 THE "PRIVATE CORRADO PICCOLI PURPLE HEART PRESERVATION ACT;" SUPPORT FOR HR 5337 "VETERAN PRESCRIPTION CONTINUITY ACT."
Referred to the Subcommittee on Health.
Referred to the House Committee on Veterans' Affairs.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Tariff (miscellaneous tariff bills)
Junker & Nakachi is retained by Nufarm Americas, Inc. to faciliate the passage of duty suspension bills HR5346 (Imazapyr) & 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2,4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2,4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p 2-ethylhexyl ester),
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2015 · fourth_quarter · Tariff (miscellaneous tariff bills)
Junker & Nakachi is retained by Nufarm Americas, Inc. to facilitate the passage of duty suspension bills HR 5346 (lmazapyr) & 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2, 4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2, 4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p 2-ethylhexyl ester), 5341 (Gibberellic Acid), 5432 (2-methyl-4-chlorophenoxyacetic acid), 5433 (2-ethylhexyl (4-chloro-2-methylphenoxy) acetate). 5434 (2-Methyl-4-chlorophenoxyacetic acid, dimethylene salt) and 5345 (MCPB Acid and MCPB Sodium Salt).
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2015 · third_quarter · Tariff (miscellaneous tariff bills)
Junker & Nakachi is retained by Nufarm Americas, Inc. to facilitate the passage of duty suspension bills HR 5346 (lmazapyr) & 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2, 4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2, 4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p 2-ethylhexyl ester), 5341 (Gibberellic Acid), 5432 (2-methyl-4-chlorophenoxyacetic acid), 5433 (2-ethylhexyl (4-chloro-2-methylphenoxy) acetate). 5434 (2-Methyl-4-chlorophenoxyacetic acid, dimethylene salt) and 5345 (MCPB Acid and MCPB Sodium Salt).
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2015 · second_quarter · Tariff (miscellaneous tariff bills)
Junker & Nakachi is retained by Nufarm Americas, Inc. to facilitate the passage of duty suspension bills HR 5346 (lmazapyr) & 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2, 4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2, 4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p 2-ethylhexyl ester), 5341 (Gibberellic Acid), 5432 (2-methyl-4-chlorophenoxyacetic acid), 5433 (2-ethylhexyl (4-chloro-2-methylphenoxy) acetate). 5434 (2-Methyl-4-chlorophenoxyacetic acid, dimethylene salt) and 5345 (MCPB Acid and MCPB Sodium Salt).
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2015 · first_quarter · Tariff (miscellaneous tariff bills)
Joel R. Junker & Associates is retained by Nufarm Americas, Inc. to facilitate the passage of duty suspension bills HR 5346 (lmazapyr) & 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2, 4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2, 4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p 2-ethylhexyl ester), 5341 (Gibberellic Acid), 5432 (2-methyl-4-chlorophenoxyacetic acid), 5433 (2-ethylhexyl (4-chloro-2-methylphenoxy) acetate). 5434 (2-Methyl-4-chlorophenoxyacetic acid, dimethylene salt) and 5345 (MCPB Acid and MCPB Sodium Salt).
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
| Republican |
| CO |
| Rob Bishop | Republican | UT |
| Scott H. Peters | Democratic | CA |
| Walter B. Jones | Republican | NC |